Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464438 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis
A Phase 4 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 4
- Development phase
- 171
- Enrollment target
NCT00464438 is a Phase 4 study that has completed, run by Allergan. The registered enrollment target is 171 participants.
The verdict
NCT00464438, a Phase 4 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 171 participants
- Enrollment target
Study Summary
This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age
Interventions
- DRUG gatifloxacin
- DRUG moxifloxacin 0.5% eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00464438
The ClinicalTrials.gov registry entry for NCT00464438 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gatifloxacin is the first listed.
NCT00464438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00464438 about?
NCT00464438 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis". This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age
What is the current status of trial NCT00464438?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 171 participants. The study started on 2007-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00464438?
The interventions under investigation include: gatifloxacin (DRUG), moxifloxacin 0.5% eye drops (DRUG).
Who is sponsoring clinical trial NCT00464438?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.